• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Dynatronics promotes COO Baker to replace von Jako as CEO | Personnel Moves, August 30, 2019

Dynatronics promotes COO Baker to replace von Jako as CEO | Personnel Moves, August 30, 2019

August 30, 2019 By Brad Perriello

Dynatronics CEO Brian BakerAfter deciding this week that its CEO needs to be based in Eagan, Minn., and with chief executive Chris von Jako unwilling to relocate his family, Dynatronics (NSDQ:DYNT) promoted COO Brian Baker to the corner office, effective August 28.

“After thoughtful consideration, the board of directors determined that the company’s CEO needs to be based in our Eagan, Minnesota facility,” chairwoman Erin Enright said in prepared remarks. “Dr. von Jako, who resides in the Boston area, determined that he and his family were not in a position to relocate at this time and he made the decision to pursue other opportunities. On behalf of the board of directors, I thank Dr. von Jako for his dedicated service and meaningful contributions to the company.”

Baker joined Cottonwood Heights, Utah-based Dynatronics in early 2018, after the departure of co-founder, chairman & CEO Kelvyn Cullimore. The company brought former former NinePoint Medical CEO von Jako on in July of that year; just this past June it lifted Baker into the COO role.

“I have had the pleasure of working with Brian for many years and have witnessed firsthand his ability to effectively lead an organization and drive meaningful change,” Enright said. “He brings decades of proven leadership experience, most recently in key operational roles at Dynatronics. His promotion to CEO is a natural progression in his leadership of the company.”

“I am honored and grateful to the board of directors for the opportunity to lead the organization as the chief executive based in our Eagan facility,” Baker added. “Dynatronics is well regarded in the markets we serve for providing trusted, high-quality restorative products. I see significant opportunity to expand the reach and depth of our customer relationships and to accelerate Dynatronics’ growth.”

 Harmonic Bionics names ex-Mazor chief Prentice as CEO
Harmonic Bionics said this week that it named former MZOR chief executive Christopher Prentice to succeed co-founder Youngmok Yun as CEO.

“As Harmonic Bionics prepares for the commercialization of robotic upper extremity rehabilitation system, we sought a leader who had direct experience in helping early stage robotic companies achieve their goals,” said Yun, who stayed on as CTO/COO. “Chris is an outstanding choice to lead the company into the market.”

“Harmonic Bionics has a brilliant product development team and an innovative system that can advance the field of neurorehabilitation. Based on my experience and knowledge of the commercialization of robotic systems, gained at both Intuitive and Mazor, I am very excited about the opportunity at Harmonic Bionics and I am honored to join the team,” Prentice added.

In addition to time as CCO and CEO at Mazor Robotics, Prentice was VP of commercial integration at Medtronic (NYSE:MDT) and logged time at Intuitive Surgical (NSDQ:ISRG) and Johnson & Johnson (NYSE:JNJ).
Read more

 Echosens nabs ex-AxoGen CCO Gingrich for North America CEO
Echosens said this week that it nabbed former AxoGen Inc. (NSDQ:AXGN) chief commercial officer Jon Gingrich as CEO of Echosens North America out of its Waltham, Mass., regional headquarters.

Apart from his stint at Axogen, Gingrich worked at Hologic (NSDQ:HOLX) and Boston Scientific (NYSE:BSX), Echosens said.

“Jon exemplifies the type of business leadership that will grow our presence in the U.S., increase domestic and international adoption of FibroScan technology and drive the overall success of our global enterprise. An accomplished executive with a diverse skillset for leading and scaling business operations, Jon has demonstrated significant success in transforming businesses to sustainable record level growth. He will play a major role in accelerating our position throughout the U.S. healthcare system, and together with Dominique Legros, our newly appointed CEO at the Echosens Group in Paris, we will positively impact our growth worldwide,” chairman & co-founder Laurent Sandrin said in prepared remarks.

“With the looming worldwide epidemic of liver disease, FibroScan products and services take on even greater importance in supporting physicians in their assessment and management of patients with liver diseases. My commitment is to broaden the utilization of these technology solutions, serve an even greater number of providers and payers in both public and private sectors throughout the U.S. healthcare system and make a critical difference in the lives of individuals who face chronic liver disease. Now more than ever, Echosens is positioned for extraordinary growth as it meets these challenges head-on,” Gingrich added.
Read more

 Fresenius names Giza to succeed Brosnan as CFO
Fresenius (NYSE:FMS) this week appointed Helen Giza to replace Mike Brosnan as CEO effective Nov. 1.

Giza was chief integration & divestiture officer at pharma firm Takeda, where she was previously CFO for its U.S. business.

“We look forward to welcoming Helen to our team. Along with her international financial expertise, Helen brings great experience in the area of acquisitions and successful integration within the healthcare sector,” chairman & CEO Rice Powell said in prepared remarks.

“I am excited to be joining Fresenius Medical Care, the market leader in dialysis. This new role is a wonderful opportunity to be part of Fresenius Medical Care’s continued success,” Giza added.
Read more

 Penumbra adds president to CFO Kosaraju’s title
Penumbra (NYSE:PEN) yesterday added the title of president to CFO Sri Kosaraju’s job description.

“This promotion formalizes the additional responsibilities that Sri has taken on over the recent past and allows us greater capacity to focus on our growing opportunities here at Penumbra. I am proud of Sri and our many other growing leaders who fully embrace Penumbra’s culture and mission of being one of the most innovative companies in healthcare,” chairman & CEO Adam Elsesser said in prepared remarks. “I am extremely excited and committed to leading Penumbra for many years ahead as we embark on the next chapter.”

“I’m more enthusiastic than ever before about the future of Penumbra. We are building a world-class organization and an environment that allows us to go after even more significant challenges. I am honored to be part of this team and look forward to working more closely with Adam as the company continues to grow and innovate,” Kosaraju added.
Read more

  • ATL Technology names Scadden as new CFO
  • McCreery to retire as Iradimed COO next year
  • Orchestra BioMed appoints Donohoe as CMO
  • Kelly-Falls tapped to lead Cook Medical’s global supply chain
  • UBS lures Deutsche Bank’s Damergy to lead medtech investment arm

Filed Under: Business/Financial News, Featured Tagged With: ATL Technology, Cook Medical, Dynatronics Corp, Echosens, Fresenius, Harmonic Bionics, Iradimed Corp, Orchestra BioMed, Penumbra Inc., Personnel Moves, UBS

In case you missed it

  • Calyxo raises $32.7M for kidney stone treatment
  • Getinge anesthesia systems recall is Class I
  • RefleXion closes $125M debt facility
  • Senseonics announces equity grants to employees
  • New data backs Aerin’s RhinAer for treating chronic rhinitis
  • Enovis completes Insight Medical acquisition
  • Orchestra BioMed to go public, partner with Medtronic on cardiac neuromodulation therapy
  • Memic Innovative Surgery is now Momentis Surgical
  • Lyra Therapeutics appoints new chief medical officer
  • Masimo’s SafetyNet monitoring reduced length of COVID-19 hospital stays, study says
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
  • Teva appoints former Vertex exec as new head of R&D, CMO
  • Enovis partners with Kelvi on hot and cold therapies
  • West Pharmaceutical Services debuts new needle syringe system
  • Titan Medical names Cary G. Vance as new president, CEO
  • Acutus completes first closing in left-heart access portfolio sale to Medtronic
  • FDA clears Intuitive, Siemens Healthineers imaging integration for robotic bronchoscopy

RSS From Medical Design & Outsourcing

  • FDA can’t explain drop in device recalls, but experts point to COVID disruptions
    The FDA acknowledged interruptions with notifications from recalling firms during the pandemic, while regulatory experts point to fewer inspections and fewer procedures. FDA medical device product recalls dropped last year to their lowest level since 2013, according to a Medical Design & Outsourcing analysis of recall data from the regulatory agency. Medtech regulatory experts said the COVID-19… […]
  • DeviceTalks Boston 2022: Here’s what you missed on the show floor
    At DeviceTalks Boston 2022, there was a wealth of expertise to be had from exhibitors including Viant, ICS, PSN Labs, Propel and more. From stories of overcoming challenges during the COVID-19 pandemic to medical device materials pitfalls to avoid, MassDevice and MDO executive editor Chris Newmarker hit the DeviceTalks Boston show floor to discover insights. […]
  • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
    All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
  • Meddux opens new facility in Colorado
    Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • BBS Automation has a deal to buy medtech supplier Kahle Automation
    BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
  • How safe is health information after the overturning of Roe?
    The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS